Becton, Dickinson and Co. | BDX - تكلفة المبيعات





تكلفة المبيعات تغيير تاريخ
Abbott USD 5.94B 642M 2026-06
Agilent USD 845M 7M 2026-03
Align Technology USD 298.76M 4.74M 2026-06
AngioDynamics USD 37.29M 786K 2025-09
Baxter International USD 1.93B 118M 2026-06
Becton, Dickinson and Co. USD 2.67B 108M 2026-06
Bio-Rad Laboratories USD 305.2M 22.5M 2026-06
Boston Scientific USD 1.86B 29M 2026-06
Cooper Companies USD 393.8M 17M 2026-03
Danaher USD 2.65B 294M 2026-06
Dentsply International USD 405M 48M 2026-06
Dexcom USD 478.4M 36.8M 2026-06
Edwards Lifesciences USD 392.4M 29.8M 2026-06
Globus Medical USD 271M 7.41M 2026-06
Insulet USD 239.1M 6.4M 2026-06
Integra LifeSciences USD 188.86M 10.15M 2026-06
Intuitive Surgical USD 931.9M 8.4M 2026-06
J&J USD 8B 67M 2026-06
Medtronic USD 3.8B 195M 2026-03
Solventum Corp USD 923M 12M 2026-06
Stryker USD 2.26B 106M 2026-06
Tandem Diabetes Care USD 109.78M 653K 2026-06
Teleflex USD 238.62M 2.21M 2026-06
Terumo JPY 133.27B 18.03B 2026-06
Thermo Fisher Scientific USD 7.54B 577M 2026-06
Zimmer Biomet Holdings USD 815.9M 77.6M 2026-06